- Home
- ZTO vs NXPLW Comparison
ZTO vs NXPLW Comparison
Compare ZTO & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTO
- NXPLW
- Stock Information
- Founded
- ZTO 2002
- NXPLW N/A
- Country
- ZTO China
- NXPLW United States
- Employees
- ZTO N/A
- NXPLW 166
- Industry
- ZTO Advertising
- NXPLW Telecommunications Equipment
- Sector
- ZTO Consumer Discretionary
- NXPLW Telecommunications
- Exchange
- ZTO Nasdaq
- NXPLW Nasdaq
- Market Cap
- ZTO N/A
- NXPLW N/A
- IPO Year
- ZTO 2016
- NXPLW N/A
- Fundamental
- Price
- ZTO $19.15
- NXPLW $0.19
- Analyst Decision
- ZTO Buy
- NXPLW
- Analyst Count
- ZTO 4
- NXPLW 0
- Target Price
- ZTO $25.13
- NXPLW N/A
- AVG Volume (30 Days)
- ZTO 2.8M
- NXPLW 6.4K
- Earning Date
- ZTO 05-14-2025
- NXPLW 03-31-2025
- Dividend Yield
- ZTO 3.59%
- NXPLW N/A
- EPS Growth
- ZTO N/A
- NXPLW N/A
- EPS
- ZTO 1.12
- NXPLW N/A
- Revenue
- ZTO $6,066,599,984.00
- NXPLW $66,482,000.00
- Revenue This Year
- ZTO $18.23
- NXPLW N/A
- Revenue Next Year
- ZTO $12.96
- NXPLW N/A
- P/E Ratio
- ZTO $17.03
- NXPLW N/A
- Revenue Growth
- ZTO 15.26
- NXPLW 179.89
- 52 Week Low
- ZTO $16.34
- NXPLW $0.25
- 52 Week High
- ZTO $27.50
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- ZTO 51.45
- NXPLW N/A
- Support Level
- ZTO $18.48
- NXPLW N/A
- Resistance Level
- ZTO $19.67
- NXPLW N/A
- Average True Range (ATR)
- ZTO 0.74
- NXPLW 0.00
- MACD
- ZTO 0.12
- NXPLW 0.00
- Stochastic Oscillator
- ZTO 84.38
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.